Anti-malaria drug hydroxychloroquine’s coronavirus trials to resume: WHO - India Today 04-Jun-2020

Anti-malaria drug hydroxychloroquine’s coronavirus trials to resume: WHO - India Today

WHO has decided to resume the trials for anti-malaria drug hydroxychloroquine. They were suspended last week because of concerns raised about the safety of the drug.